Passage Bio Inc (NASDAQ: PASG) on Monday, soared 22.97% from the previous trading day, before settling in for the closing price of $0.50. Within the past 52 weeks, PASG’s price has moved between $0.45 and $1.79.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company achieved an average annual earnings per share of 43.89%. With a float of $49.14 million, this company’s outstanding shares have now reached $54.94 million.
Let’s determine the extent of company efficiency that accounts for 58 employees. In terms of profitability, gross margin is 59.18%, operating margin of -1261.43%, and the pretax margin is -1163.73%.
Passage Bio Inc (PASG) Insider Activity
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Passage Bio Inc is 20.44%, while institutional ownership is 42.68%. The most recent insider transaction that took place on Sep 19 ’24, was worth 27,903. In this transaction 10% Owner of this company sold 39,300 shares at a rate of $0.71, taking the stock ownership to the 7,794,569 shares. Before that another transaction happened on Sep 17 ’24, when Company’s 10% Owner sold 111,400 for $0.73, making the entire transaction worth $81,322. This insider now owns 7,859,500 shares in total.
Passage Bio Inc (PASG) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 43.89% per share during the next fiscal year.
Passage Bio Inc (NASDAQ: PASG) Trading Performance Indicators
Passage Bio Inc (PASG) is currently performing well based on its current performance indicators. A quick ratio of 5.15 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.17, a number that is poised to hit -0.22 in the next quarter and is forecasted to reach -0.71 in one year’s time.
Technical Analysis of Passage Bio Inc (PASG)
Looking closely at Passage Bio Inc (NASDAQ: PASG), its last 5-days average volume was 0.42 million, which is a jump from its year-to-date volume of 0.27 million. As of the previous 9 days, the stock’s Stochastic %D was 44.12%. Additionally, its Average True Range was 0.08.
During the past 100 days, Passage Bio Inc’s (PASG) raw stochastic average was set at 24.32%, which indicates a significant decrease from 71.13% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 139.08% in the past 14 days, which was higher than the 89.85% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.6138, while its 200-day Moving Average is $0.9910. However, in the short run, Passage Bio Inc’s stock first resistance to watch stands at $0.7170. Second resistance stands at $0.8131. The third major resistance level sits at $0.9361. If the price goes on to break the first support level at $0.4979, it is likely to go to the next support level at $0.3749. Should the price break the second support level, the third support level stands at $0.2788.
Passage Bio Inc (NASDAQ: PASG) Key Stats
Market capitalization of the company is 36.14 million based on 61,767K outstanding shares. Right now, sales total 0 K and income totals -102,060 K. The company made 0 K in profit during its latest quarter, and -19,340 K in sales during its previous quarter.
